IRCT20081019001369N2招募中2 期
Clinical trial of berberine against COVID-19
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Patients with covid-19 symptoms
- •Indication of home quarantine and outpatient medication
排除标准
- •Patients over 65 years of age
- •Patients connected to a catheter or under chemotherapy
- •Patients taking cytotoxic drugs or corticosteroids
- •Child patients
- •Pregnant and lactating patients
- •Diabetic patients
- •Patients with severe renal insufficiency as well as liver failure
研究者
相似试验
招募中
2 期
Effect of minocycline on COVID-19Covid-19.COVID-19 DiseaseU07.1IRCT20081019001369N4Mashhad University of Medical Sciences40
进行中（未招募）
1 期
Treatments of COVID-19 in primary care in the NetherlandsPatients with symptomatic COVID-19 in the community and in primary care, who are at higher risk of a complicated illness course.MedDRA version: 23.0Level: PTClassification code: 10084268Term: COVID-19 Class: 100000004862CTIS2022-501559-99-00Maastricht University682
招募中
不适用
Randomized Clinical Trial of the antibacterial effect, clinical and radiographic success of endodontic treatment in primary teethRBR-65336kValdineia Maria Tognetti
Unknown
1 期
A randomized clinical trial on the antimicrobial activity and safety of 0.5% chitosan mouth sprayHealthy with ASA (American association of Anesthesiologists) class 1 and class 20.5% Chitosan, Mouth spray, Antimicrobial activity, SafetyTCTR20221129002Faculty of Dentistry, Khon Kaen University60
Unknown
2 期
Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.Pharmacological ActionNCT04320277Hospital of Prato200